Marinus Pharmaceuticals Statistics

Total Valuation

MRNS has a market cap or net worth of $17.02 million. The enterprise value is $70.70 million.

Market Cap	17.02M
Enterprise Value	70.70M

Important Dates

The last earnings date was Tuesday, November 12, 2024, after market close.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

MRNS has 55.08 million shares outstanding. The number of shares has increased by 12.09% in one year.

Current Share Class	55.08M
Shares Outstanding	55.08M
Shares Change (YoY)	+12.09%
Shares Change (QoQ)	+0.29%
Owned by Insiders (%)	0.44%
Owned by Institutions (%)	58.05%
Float	39.88M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.56
Forward PS	0.32
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	2.25
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.66

Current Ratio	1.66
Quick Ratio	1.33
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-7.17

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-57.97%
Return on Capital (ROIC)	-79.94%
Revenue Per Employee	$189,554
Profits Per Employee	-$846,331
Employee Count	166
Asset Turnover	0.24
Inventory Turnover	21.75

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -94.99% in the last 52 weeks. The beta is 1.26, so MRNS's price volatility has been higher than the market average.

Beta (5Y)	1.26
52-Week Price Change	-94.99%
50-Day Moving Average	1.15
200-Day Moving Average	3.12
Relative Strength Index (RSI)	25.73
Average Volume (20 Days)	6,673,848

Short Selling Information

The latest short interest is 5.66 million, so 10.28% of the outstanding shares have been sold short.

Short Interest	5.66M
Short Previous Month	3.49M
Short % of Shares Out	10.28%
Short % of Float	14.20%
Short Ratio (days to cover)	1.09

Income Statement

In the last 12 months, MRNS had revenue of $31.47 million and -$140.49 million in losses. Loss per share was -$2.47.

Revenue	31.47M
Gross Profit	-71.31M
Operating Income	-122.62M
Pretax Income	-146.88M
Net Income	-140.49M
EBITDA	-118.93M
EBIT	-122.62M
Loss Per Share	-$2.47

Full Income Statement

Balance Sheet

The company has $42.18 million in cash and $95.19 million in debt, giving a net cash position of -$53.01 million or -$0.96 per share.

Cash & Cash Equivalents	42.18M
Total Debt	95.19M
Net Cash	-53.01M
Net Cash Per Share	-$0.96
Equity (Book Value)	-66.74M
Book Value Per Share	-1.21
Working Capital	22.90M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-114.75M
Capital Expenditures	-1.19M
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	-226.64%
Operating Margin	-389.70%
Pretax Margin	-446.49%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-403.33%

Dividends & Yields

MRNS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.09%
Shareholder Yield	-12.09%
Earnings Yield	-825.40%
FCF Yield	n/a

Analyst Forecast

The average price target for MRNS is $4.28, which is 1,285.11% higher than the current price. The consensus rating is "Buy".

Price Target	$4.28
Price Target Difference	1,285.11%
Analyst Consensus	Buy
Analyst Count	12
Revenue Growth Forecast (5Y)	56.49%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on September 23, 2020. It was a reverse split with a ratio of 0.25:1.

Last Split Date	Sep 23, 2020
Split Type	Reverse
Split Ratio	0.25:1

Scores

MRNS has an Altman Z-Score of -18.88 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-18.88
Piotroski F-Score	3